Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2007-08-07
Saed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S268400
Reexamination Certificate
active
10491613
ABSTRACT:
Tetrazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, and panic, as well as in the treatment of pain and other diseases.
REFERENCES:
CAOLD Accession No. CA55: 7397b, Hopff, Heinrich et al, “Isopropenylation.”
Chen Chixu
Cosford Nicholas D. P.
Reger Thomas S.
Roppe Jeffrey R.
Smith Nicholas D.
Coppins Janet L.
Krovatin William
Merck & Co. , Inc.
Rubin David
Saed Kamal A.
LandOfFree
Heteroaryl substituted tetrazole modulators of metabotrophic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl substituted tetrazole modulators of metabotrophic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl substituted tetrazole modulators of metabotrophic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3884001